Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
Novartis
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Tasigna
(nilotinib) / Novartis, Inhibikase
Rixathon
(rituximab biosimilar) / Kyowa Kirin, Sandoz
